Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | TRAP1 | Q12931 | 1/20 | 0.42 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.41 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.41 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 6/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2922386 | 0.94 | HIF1A (0.52) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| Sulfuric Acid SCHEMBL699062 | 0.86 | HIF1A (0.56) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| SCHEMBL34778 | 0.82 | HIF1A (0.42) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| SCHEMBL31146915 | 0.79 | HIF1A (0.78) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| Sulfuric Acid SCHEMBL21933060 | 0.79 | TRAP1 (0.47) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| Sulfuric Acid SCHEMBL30331189 | 0.79 | HIF1A (0.47) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| Trifluoromethanesulfonic Acid SCHEMBL34640 | 0.78 | ALDH1A1 (0.39) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| Sulfuric Acid SCHEMBL20975185 | 0.78 | HIF1A (0.50) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| Hydrochloric Acid SCHEMBL6060715 | 0.77 | HIF1A (0.74) | HIF1AALDH1A1CYP1A2CYP2D6TSHR | |
| Bromide SCHEMBL2446042 | 0.77 | HIF1A (0.74) | HIF1AALDH1A1CYP1A2CYP2D6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019016115-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED ARYL KETONES | BASF Agro B.V. (NL) | 2019-01-24 | — | — | WO | claimed |
| US-20250368598-A1 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | BHATTACHARYA SHRABANTI (US) | 2025-12-04 | — | — | US | disclosed |
| EP-4543841-A2 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | The University of North Carolina at Chapel Hill (US) | 2025-04-30 | — | — | EP | disclosed |
| WO-2023250180-A2 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2023-12-28 | — | — | WO | disclosed |
| US-20230101362-A1 | RNA STABILIZATION | TEAM MEDICAL LLC | 2023-03-30 | — | — | US | disclosed |
| WO-2023044455-A2 | RNA STABILIZATION | TEAM MEDICAL LLC (US) | 2023-03-23 | — | — | WO | disclosed |
| CN-107710462-B | Electrochemical hydrogen storage electrode and battery | 巴斯夫公司 | 2022-08-02 | — | — | CN | disclosed |
| EP-3292578-B1 | ELECTROCHEMICAL HYDROGEN STORAGE ELECTRODES AND CELLS | BASF CORP (US) | 2021-02-24 | — | — | EP | disclosed |
| WO-2020152200-A1 | PROCESS FOR PREPARATION OF HETEROARYLKETONES | BASF SE (DE) | 2020-07-30 | — | — | WO | disclosed |
| US-10243240-B2 | Electrolytes and metal hydride batteries | BASF CORPORATION (US) | 2019-03-26 | — | — | US | disclosed |
| WO-2019016115-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED ARYL KETONES | BASF Agro B.V. (NL) | 2019-01-24 | — | — | WO | disclosed |
| EP-3292578-A1 | ELECTROCHEMICAL HYDROGEN STORAGE ELECTRODES AND CELLS | BASF Corporation (US) | 2018-03-14 | — | — | EP | disclosed |
| EP-3218955-A1 | ELECTROLYTES AND METAL HYDRIDE BATTERIES | BASF Corporation (US) | 2017-09-20 | — | — | EP | disclosed |
| US-20160329560-A1 | Electrochemical Hydrogen Storage Electrodes and Cells | BASF CORPORATION (US) | 2016-11-10 | — | — | US | disclosed |
| US-20160141724-A1 | Electrolytes and Metal Hydride Batteries | BASF CORPORATION | 2016-05-19 | — | — | US | disclosed |
| US-20160141725-A1 | Electrolytes and Metal Hydride Batteries | BASF CORPORATION | 2016-05-19 | — | — | US | disclosed |
| US-20160141727-A1 | Electrolytes and Metal Hydride Batteries | BASF CORPORATION | 2016-05-19 | — | — | US | disclosed |
| US-20160141726-A1 | Electrolytes and Metal Hydride Batteries | BASF CORPORATION | 2016-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250368598-A1 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | CA4, CA12, CA14 | HIF1A 982/4885ALDH1A1 688/4885CYP1A2 1202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.